$7.08
-0.23-3.15%
Last update: Nov 10, 4:27 PM
Rockwell Medical Inc
RMTINASDAQ
Rockwell Medical fell 32.6% from $10.50 to $7.08, behind the S&P 500's +9.8%. Its worst day was Jun 29 (−9.8%), and its low came Jul 1 at $5.19.
Nov 11, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $0.00 beat the $-0.40 estimate on $15.9M revenue (est. $16.5M); FY revenue guidance of $65.0M–$70.0M against the $69.0M consensus.
−9.0% · S&P 500 +0.1%
Story events cover the past 12 months · Times ET
Rockwell Medical shares rose 14.4%, while the S&P 500 rose 0.7%.
+14.4% · S&P 500 +0.7%
Rockwell Medical closed at its highest level of the year, 20.0% above where the year started.
+31.6%, the year's best day, on 2M shares, the year's heaviest volume · S&P 500 −2.0%
Rockwell Medical shares rose 11.0%, while the S&P 500 rose 0.3%.
+11.0% · S&P 500 +0.3%
EPS of $0.20 missed the $0.30 estimate on $18.3M revenue (est. $18.6M); FY revenue guidance of $65.0M–$70.0M against the $75.5M consensus.
−9.4% · S&P 500 −1.8%
EPS of $-0.10 beat the $-0.20 estimate on $17.3M revenue (est. $18.1M); FY revenue guidance of $70.0M–$75.0M against the $74.0M consensus.
−3.6% · S&P 500 −0.3%
Rockwell Medical closed at its lowest level of the year, 50.6% below where the year started.
−5.7% · S&P 500 −0.1%
EPS of $-0.40 beat the $-2.20 estimate on $17.8M revenue (est. $17.8M); FY revenue guidance of $70.0M–$75.0M against the $72.5M consensus.
+4.2% · S&P 500 +0.7%
Vantive, a vital organ therapy company with a 70-year legacy of kidney care innovation, today announced that it has entered into a definitive agreement with Rockwell Medical, Inc.
+17.1% · S&P 500 +0.3%
Where it ended: a close of $7.08 on Nov 11, 2026. Up next: Q3 2026 earnings on Nov 12, 2026 (EPS est. $-0.17, revenue est. $18.2M).
Nothing in the past 12 months.
All RMTI dividend historyReplay the year: the line draws itself and stops at each of the 9 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for RMTI and SPY from Benzinga historical bars. Not investment advice.
